Ferguson Wellman Capital Management’s Allergan Inc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q2
Sell
-1,284
Closed -$344K 344
2016
Q1
$344K Hold
1,284
0.01% 244
2015
Q4
$401K Buy
1,284
+32
+3% +$9.99K 0.02% 253
2015
Q3
$340K Hold
1,252
0.02% 260
2015
Q2
$380K Buy
+1,252
New +$380K 0.02% 257
2015
Q1
Sell
-3,800
Closed -$808K 345
2014
Q4
$808K Hold
3,800
0.03% 217
2014
Q3
$677K Sell
3,800
-160
-4% -$26.6K 0.03% 207
2014
Q2
$670K Sell
3,960
-520
-12% -$81K 0.03% 211
2014
Q1
$556K Sell
4,480
-50
-1% -$6.09K 0.02% 214
2013
Q4
$503K Hold
4,530
0.02% 214
2013
Q3
$410K Sell
4,530
-373
-8% -$33.5K 0.02% 229
2013
Q2
$413K Buy
+4,903
New +$509K 0.03% 137

Other funds holding AGN

Ferguson Wellman Capital Management's AGN Position: Q2 2016 in Review

Ferguson Wellman Capital Management sold out of Allergan Inc (AGN) in Q2 2016, closing a stake of 1,284 shares — an estimated $344K sold.

Ferguson Wellman Capital Management first reported a position in AGN in Q2 2013 and held it in 11 quarters. The position peaked at $808K in Q4 2014. 13 funds tracked by Wall St. Rank hold AGN as of Q2 2016.

  • Ferguson Wellman Capital Management reported no remaining Allergan Inc position as of Q2 2016 after selling out during the quarter.
  • Ferguson Wellman Capital Management sold 1,284 Allergan Inc shares in Q2 2016, an estimated $344K.
  • Ferguson Wellman Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 11 quarters.
  • Ferguson Wellman Capital Management's Allergan Inc position peaked at $808K in Q4 2014.
  • 13 funds tracked by Wall St. Rank held Allergan Inc as of Q2 2016.

Based on Ferguson Wellman Capital Management's 13F filing for Q2 2016, filed 15 Jul 2016.